155 related articles for article (PubMed ID: 11790188)
1. Follicular toxic effects of chimeric anti-epidermal growth factor receptor antibody cetuximab used to treat human solid tumors.
Kimyai-Asadi A; Jih MH
Arch Dermatol; 2002 Jan; 138(1):129-31. PubMed ID: 11790188
[No Abstract] [Full Text] [Related]
2. Two cases of acneiform eruption induced by inhibitor of epidermal growth factor receptor.
Gencoglan G; Ceylan C
Skin Pharmacol Physiol; 2007; 20(5):260-2. PubMed ID: 17641540
[TBL] [Abstract][Full Text] [Related]
3. [Contribution to acneiform eruptions by epidermal growth factor receptor inhibitors].
Bodet D; Bartralot R; Mollet J; Heras C; García-Patos V
Actas Dermosifiliogr; 2006 Mar; 97(2):148-9. PubMed ID: 16595122
[No Abstract] [Full Text] [Related]
4. Papulopustular drug eruption due to an epidermal growth factor receptor inhibitors, erlotinib and cetuximab.
Bragg J; Pomeranz MK
Dermatol Online J; 2007 Jan; 13(1):1. PubMed ID: 17511934
[TBL] [Abstract][Full Text] [Related]
5. Perifollicular xanthomas associated with epidermal growth factor receptor inhibitor therapy.
Eames T; Kroth J; Flaig MJ; Ruzicka T; Wollenberg A
Acta Derm Venereol; 2010 Mar; 90(2):202-3. PubMed ID: 20169314
[No Abstract] [Full Text] [Related]
6. [Acneiform eruptions induced by cetuximab].
Walon L; Gilbeau C; Lachapelle JM
Ann Dermatol Venereol; 2003 Apr; 130(4):443-6. PubMed ID: 12843857
[TBL] [Abstract][Full Text] [Related]
7. [Acneiform skin eruption in patients with metastatic colorectal carcinoma].
Gethöffer K; Schneider LA; Peters T; Weber L; Scharffetter-Kochanek K
Hautarzt; 2006 Jul; 57(7):628-31. PubMed ID: 16034631
[No Abstract] [Full Text] [Related]
8. Rosaceiform eruption induced by cetuximab.
Fernández-Torres R; Martínez Gomez W; Cuevas Santos J; Paradela S; Fonseca Capdevila E
Eur J Dermatol; 2010; 20(3):392-3. PubMed ID: 20172848
[No Abstract] [Full Text] [Related]
9. Papulopustular eruption associated with panitumumab.
Korman JB; Ward DB; Maize JC
Arch Dermatol; 2010 Aug; 146(8):926-7. PubMed ID: 20713838
[No Abstract] [Full Text] [Related]
10. Predictors of Tumor Response to Cetuximab and Panitumumab in 116 Patients and a Review of Approaches to Managing Skin Toxicity.
Jaka A; Gutiérrez-Rivera A; López-Pestaña A; del Alcázar E; Zubizarreta J; Vildosola S; Arregui MA; Sarasqueta C; Lobo C; Tuneu A
Actas Dermosifiliogr; 2015; 106(6):483-92. PubMed ID: 25798804
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of cetuximab combined with chemotherapy for patients with advanced colorectal cancer and unclear K-ras status].
Guo GF; Xia LP; Qiu HJ; Xu RH; Zhang B; Jiang WQ; Zhou FF; Wang F
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):777-81. PubMed ID: 21163071
[TBL] [Abstract][Full Text] [Related]
12. Images in clinical medicine. Cetuximab-associated acneiform eruption.
Moss JE; Burtness B
N Engl J Med; 2005 Nov; 353(19):e17. PubMed ID: 16282170
[No Abstract] [Full Text] [Related]
13. [Acneiform eruption secondary to cetuximab].
Herrera-Acosta E; Martín-Ezquerra G; Iglesias M; Umbert P
Actas Dermosifiliogr; 2005 May; 96(4):252-4. PubMed ID: 16476378
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune dermatologic toxicities from immune checkpoint blockade with anti-PD-1 antibody therapy: a report on bullous skin eruptions.
Jour G; Glitza IC; Ellis RM; Torres-Cabala CA; Tetzlaff MT; Li JY; Nagarajan P; Huen A; Aung PP; Ivan D; Drucker CR; Prieto VG; Rapini RP; Patel A; Curry JL
J Cutan Pathol; 2016 Aug; 43(8):688-96. PubMed ID: 27086658
[TBL] [Abstract][Full Text] [Related]
15. [Cutaneous side effects of EGF-receptor inhibition and their management].
Gutzmer R; Werfel T; Kapp A; Elsner J
Hautarzt; 2006 Jun; 57(6):509-13. PubMed ID: 16205868
[TBL] [Abstract][Full Text] [Related]
16. Cetuximab-induced crusted pustular eruption with patchy alopecia.
Fischer R; Blackmon J; Rajpara A
Dermatol Online J; 2014 Oct; 20(10):. PubMed ID: 25526010
[TBL] [Abstract][Full Text] [Related]
17. Hand eruption after intravenous administration of bevacizumab.
Ruiz V; Garcia-Muret MP; Alomar A
J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):238-9. PubMed ID: 20477919
[No Abstract] [Full Text] [Related]
18. [Cutaneous side effects of EGF receptor inhibitors].
Nassar D; Soutou B; Aractingi S
Bull Cancer; 2009 Dec; 96 Suppl():S85-91. PubMed ID: 20034874
[TBL] [Abstract][Full Text] [Related]
19. Trichomegaly and poliosis of the eyelashes during cetuximab treatment of metastatic colorectal cancer.
Rodriguez NA; Ascaso FJ
J Clin Oncol; 2011 Jun; 29(18):e532-3. PubMed ID: 21483009
[No Abstract] [Full Text] [Related]
20. [Follicular drug reaction from cetuximab: a common side effect in the treatment of metastatic colon carcinoma].
Braun-Falco M; Holtmann C; Lordick F; Ring J
Hautarzt; 2006 Aug; 57(8):701-4. PubMed ID: 15991047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
